Lilly's Alzheimer's drug gets UK nod but won't be NHS-funded
The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to be funded by the NHS, according to cost-effectiveness watchdog NICE. GB is the first country in Europe to approve amyloid inhibitor Kisunla (donanemab) and only the third to do so worldwide after the US and Japan.
England’s drug-cost regulator rejected Eli Lilly’s Alzheimer’s drug for use in the country’s public health system, marking ...
Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, ...
A group of U.S. senators are digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this ...
Maggie Lilly is creating a buzz with her Party of Hive granola.
"Slim Aarons: Gold Coast" is organized by Shawn Waldron, the curator for Getty Images and manager of the Slim Aarons Archive ...
The News Leader (Staunton) on MSN17h
Five Waynesboro residents ask judge to force Lilly and Mares to certify upcoming electionA counter lawsuit asking a judge to force two Waynesboro Board of Election members to certify the Nov. 5 election was filed ...
Her willingness to challenge the status quo helped shape a new era in corporate responsibility, writes Marc Benioff.
Lilly Ledbetter may have lost in the court of law, but she won in the court of public opinion as she brought attention to the ...
US Senators are concerned that Pfizer and Eli Lilly's recent forays into direct-to-consumer distribution of medicines via ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback